Karin Meyer, PhD
Karin is Chief Executive Officer of Center for Translational Research AB, and chair of the board of its subsidiaries since 2021. She has over 30 years of experience in the pharmaceutical/life sciences area, holding executive roles in private and public/non-profit organizations. She has extensive experience in Contract Research Organisations (CROs), including as CEO for PCG Clinical Services AB/PCG Solutions AB and vice president and managing director for Quintiles Scandinavia AB. She is also the former Deputy General Director of Uppsala University Innovations and CEO for Swedish Pharmaceutical Society.
Other assignments: Board member WHO Uppsala Monitoring Center, member ALMI Invest investment committee.
Lars Bennbom has served as Chief Financial Officer since February 2022. Lars Bennbom has developed his career from experience in a number of senior and executive finance roles, in various industries and both publicly listed and privately owned companies. The last 10 years he has held positions mainly within the Life Science industry. Lars Bennbom started his career spending a number of years in public accounting with KPMG.
Lars Bennbom holds a degree of Master of Science in Business Studies and Economics from Uppsala University, Sweden.
Other assignments: Board member of Eklundshof fastigheter AB (Real estate)